Literature DB >> 8889968

Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis.

J Chen1, G C Farrell.   

Abstract

In bile duct-ligated male rats, there is a reduction of total hepatic microsomal cytochrome P450 (P450) levels and of NADPH-cytochrome P450 reductase (P450-reductase) activity, but the changes in activity of individual microsomal enzymes are nonuniform. We have proposed that the initial effect of cholestasis on microsomal proteins is a non-specific reduction caused by bile acid-mediated destruction, whereas the disproportionate lowering of male-specific P450 enzymes results from secondary down-regulation of some cytochrome P450 (CYP) genes. We report herein the results of experiments to test the first part of this hypothesis, at least as indicated by enzyme inhibition. Hepatic microsomal fractions from normal male rats were incubated at 37 degrees C with increasing concentrations of a range of bile acids selected for their varying physicochemical properties. The endpoints were catalytic activity of three individual CYP proteins, CYP 2A1 (measured as testosterone 7 alpha-hydroxylase activity), 2C11 (testosterone 2 alpha-hydroxylase and 16 alpha-hydroxylase) and 3A2 (testosterone 6 beta-hydroxylase), and the non-CYP enzymes, steroid 17 beta-dehydrogenase and P450-reductase. With 0.25 mmol/L cholic acid, a concentration exceeded in serum following bile duct ligation, there was a significant reduction in the activity of all enzymes at 4 h. Cholic acid-mediated inhibition was dose-dependent and there was no difference in inhibitory activity towards the male sex-dependent CYP 2C11 and 3A2 and the non-sex-dependent CYP 2A1 and other microsomal enzymes. Taurocholic acid was twice as potent an inhibitor as unconjugated cholic acid, the respective apparent I50 values being approximately 0.6 mmol/L compared with approximately 1.2 mmol/L. The dihydroxy bile acids, chenodeoxycholic acid and deoxycholic acid, were also more potent inhibitors than cholic acid, exhibiting I50 values in the range of 0.3-0.5 mmol/L, but the monohydroxy bile acid, lithocholic acid, was the most potent inhibitor (I50 approximately 0.2 mmol/L). Thus, the inhibitory potential of bile acids towards microsomal enzymes was inversely related to their extent of hydroxylation, while taurine conjugation enhanced the inhibitory potential of cholic acid. These data confirm the potential of bile acids to inhibit the activity of microsomal enzymes in livers of bile ductligated rats and indicate that such changes can occur with concentrations of bile acids that are physiologically relevant. Further, the results are consistent with the proposal that the disproportionately greater reduction of the male sex-dependent CYP, 2C11 and 3A2, is not explained by a destructive mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889968     DOI: 10.1111/j.1440-1746.1996.tb00095.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.

Authors:  Jiezhong Chen; Kong-Nan Zhao; Chen Chen
Journal:  Ann Transl Med       Date:  2014-01

2.  Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.

Authors:  Ylva Terelius; Robert A Figler; Svetlana Marukian; Maria S Collado; Mark J Lawson; Aaron J Mackey; David Manka; Charles W Qualls; Brett R Blackman; Brian R Wamhoff; Ajit Dash
Journal:  Chem Biol Interact       Date:  2015-12-02       Impact factor: 5.192

3.  Effect of biliary obstruction and internal biliary drainage on hepatic cytochrome P450 isozymes in rats.

Authors:  Shintaro Fukushima; Hiroyasu Okuno; Nobuyuki Shibatani; Yoshitsugu Nakahashi; Toshihito Seki; Kazuichi Okazaki
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

4.  Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.

Authors:  Ornella Baisini; Federica Benini; Felice Petraglia; Wilhelm Kuhnz; Santo Scalia; Hanns-Ulrich Marschall; Gabriele Brunetti; Horst-Dietmar Tauschel; Alberto Lanzini
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

5.  Experimental protoporphyria: effect of bile acids on liver damage induced by griseofulvin.

Authors:  María Del Carmen Martinez; Silvina Fernanda Ruspini; Susana Graciela Afonso; Roberto Meiss; Ana Maria Buzaleh; Alcira Batlle
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

6.  Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.

Authors:  Daniela Gabbia; Arianna Dalla Pozza; Laura Albertoni; Roberta Lazzari; Giorgia Zigiotto; Maria Carrara; Vincenzo Baldo; Tatjana Baldovin; Annarosa Floreani; Sara De Martin
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

7.  Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.

Authors:  Christopher Yip; Naomi C Okada; Amber Howerton; Amei Amei; Ernesto Abel-Santos
Journal:  Biochem Pharmacol       Date:  2020-11-03       Impact factor: 5.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.